Berlin - Delayed Quote EUR
Ionis Pharmaceuticals Inc (ISI.BE)
26.28
+0.38
+(1.47%)
At close: April 30 at 8:08:25 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
717,253
705,138
787,647
587,367
810,456
Cost of Revenue
10,515
11,215
9,133
14,116
10,842
Gross Profit
706,738
693,923
778,514
573,251
799,614
Operating Expense
1,179,274
1,169,030
1,132,225
983,442
814,353
Operating Income
-472,536
-475,107
-353,711
-410,191
-14,739
Net Non Operating Interest Income Expense
-91,220
-90,457
-81,497
-8,122
-9,300
Other Income Expense
99,537
105,464
101,222
160,328
-5,013
Pretax Income
-464,162
-460,068
-333,965
-257,985
-29,148
Tax Provision
-6,130
-6,171
32,321
11,737
-551
Net Income Common Stockholders
-458,032
-453,897
-366,286
-269,722
-28,597
Diluted NI Available to Com Stockholders
-458,032
-453,897
-366,286
-269,722
-28,597
Basic EPS
-3.04
-3.04
-2.56
-1.90
-0.20
Diluted EPS
-3.04
-3.04
-2.56
-1.90
-0.20
Basic Average Shares
149,514
149,514
143,000
142,000
141,000
Diluted Average Shares
149,514
149,514
143,000
142,000
141,000
Total Operating Income as Reported
-472,428
-475,081
-353,730
-410,191
-30,186
Total Expenses
1,189,789
1,180,245
1,141,358
997,558
825,195
Net Income from Continuing & Discontinued Operation
-458,032
-453,897
-366,286
-269,722
-28,597
Normalized Income
-554,743.67
-556,664.43
-434,989.14
-402,127.58
-33,254.26
Interest Expense
85,220
84,357
75,597
8,122
4,400
Net Interest Income
-91,220
-90,457
-81,497
-8,122
-9,300
EBIT
-378,942
-375,711
-258,368
-249,863
-24,748
EBITDA
-357,206
-353,721
-235,870
-227,758
-5,188
Reconciled Cost of Revenue
10,515
11,215
9,133
14,116
10,842
Reconciled Depreciation
21,736
21,990
22,498
22,105
19,560
Net Income from Continuing Operation Net Minority Interest
-458,032
-453,897
-366,286
-269,722
-28,597
Total Unusual Items Excluding Goodwill
98,006
104,121
86,966
167,602
4,747
Total Unusual Items
98,006
104,121
86,966
167,602
4,747
Normalized EBITDA
-455,212
-457,842
-322,836
-395,360
-9,935
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,294.33
1,353.57
18,262.86
35,196.42
89.74
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade